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Abstract 
Amoxicillin, which inspite of being effective is losing its importance due to less bioavailability. 
Bioavailability could be enhanced by combining the antibiotics with bioenhancers like Piperine and Ginger 
resin. The present abstract deals with the use of piperine and ginger resin in increasing the bioavailability 
of amoxicillin using the insitu SPIP method. Piperine, isolated was found to be 99 % pure and ginger resin 
contained 4.36 % w/w of gingerol. The absorption of amoxicillin increased with addition of Piperine (1.2, 
1.5, 1.8 % w/w of amoxicillin) in a dose dependant manner reaching saturation after 45 minutes wheras 
Ginger resin (6, 7, 8 % w/w of amoxicillin) failed to show this effect in the invitro studies. Piperine 
enhanced the permeation of Amoxicillin but ginger resin failed to show this effect using the insitu SPIP 
method. The method used may be appropriate for bioenhancers acting on transporters, metabolizing 
enzymes or modulators of diffusivity but not for those acting on gut motility. The combination of Piperine 
and Amoxicillin trihydarte may have a potential in reducing the dose, shortening the treatment period 
thus reducing drug-resistance problems of the antibiotic.  
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Introduction 
Three major factors namely solubility, dissolution, and intestinal permeability, affecting oral drug 
absorption can be estimated using the biopharmaceutics classification system (BCS). It classifies the drug 
into four classes: Class I (high solubility, high permeability), Class II (low solubility, high permeability), Class 
III (high solubility, low permeability) and Class IV (low solubility, low permeability). 
Some of the very commonly used antibiotics fall into Class III and Class IV category according to this 
system. One such antibiotic is Amoxicillin which has a low permeability [1] and has been classified into 
Class III drugs [2]. Amoxicillin is absorbed by passive diffusion and via active transport through oligopeptide 
carrier localized at the apical enterocyte membrane (PePT1). The drug is reported to have low 
bioavailability in rats [3] as well as in humans [4]. In spite of being an effective antibiotic, it is losing 
importance in chemotherapy due to less bioavailability. The permeability of such low permeability drugs 
can be enhanced by co administration of bioenhancers. 
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Bioenhancers are agents, which by themselves are not therapeutic entities but when combined with an 
active drug lead to the potentiation of the pharmacological effect of the drug. Such enhancers have been 
found to increase the bioavailability of a number of drugs at very low concentrations. In general, they can 
enhance the bioavailability by enhancing the passive diffusion or by inhibiting the efflux transporters [5] 
(PgP) and other multidrug resistance proteins (MRPs) [6]. Piperine and Ginger resin are known to be the 
constituents of trikatu, an Ayurvedic formulation, indicating three drugs which enhance the bioavailability 
[7]. In the present study the effect of Piperine and Ginger resin on the absorption of Amoxicillin has been 
studied using in vitro and in vivo models. 
Experimental  
Plant material: Black pepper and ginger was procured from the local market and subjected to extraction 
of the active constituents.  
Chemicals: Amoxicillin trihydrate, Atenolol and Propranolol hydrochloride were obtained as gift samples 
from IPCA laboratories, Mumbai. Urethane was procured from Sigma Aldrich, India and other chemicals 
and solvents were of analytical grade and procured from commercial sources. 
Isolation of piperine [8]: 300 g of black pepper powder was extracted with 1.5 liters of 95 % ethanol in a 
Soxhlet extractor at 60-70 °C. The solution was filtered and concentrated in vacuum on a water bath at 
60 °C. Alcoholic potassium hydroxide (10 % w/v) was added to the filtrate residue and kept overnight in a 
refrigerator at 2-8 °C. The yellow crystals of piperine were deposited at the bottom of the flask which were 
then washed and purified with organic solvents. Recrystallisation was done with acetone. Piperine crystals 
were stored for further use. 
Analysis of isolated piperine: The isolated Piperine was subjected to HPLC analysis using Microsorb-MV 
100-5 C18 column, Acetonitrile: 0.1 % orthophosphoric acid (60:40) as mobile phase, UV –Visible detector 
at 340 nm at ambient temperature and a flow rate of 1 ml/min.  
Preparation of ginger resin: 500 g of ginger powder was extracted with 2 L of 95 % ethanol in a Soxhlet 
extractor at 60-70 °C. The extract was evaporated by distillation and collection of the excess filtered 
solvent was carried out. The extract was further concentrated on a rotary evaporator. Ginger resin was 
stored for further use. 
Quantitative estimation of Ginger resin: Ginger resin sample was sent to Natural Remedies Pvt. Ltd. 
(Bangalore) for estimation of gingerol content by HPTLC. 
In vitro studies using Franz diffusion cell: Amoxicillin solution (10 mg/ml) was added to the reservoirs 
with Phosphate Buffer Solution (PBS) pH 7.4 as the medium in the diffusion cell. Varying concentrations of 
Piperine (1.2, 1.5 and 1.8 % w/w) [9] and Ginger resin (6, 7 and 8 % w/w) [9,10] were added to different 
reservoirs to check the enhancement in diffusion across the synthetic semi permeable membrane. 
Invitro studies using non everted gut sac method [3]: The pig intestine was procured from Deonar 
slaughter house, Mumbai, India. It was cleaned and sacs of about 3 cm in length were made from the 
ileum.  The empty sac was filled with 1 ml of amoxicillin (6 mg/ml) in PBS (pH 7.4) using a blunted syringe. 
The needle was then slipped off carefully, and the loose ligature on the proximal end was tightened. The 
serosal compartment contained buffer in the sac. The distended sac was placed inside organ tube of organ 
bath containing 50 ml PBS. This gut sac bath was surrounded by a water jacket maintained at 37 ± 0.5 °C. 
The mucosal fluid compartment content was continuously mixed with air bubbles using an aerator. At 
predetermined intervals, 5 ml of sample was withdrawn from the organ tube and same volume was 
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replaced with fresh buffer. The concentration of drug that traversed intestinal surface was monitored at 
273 nm spectrophotometrically. Experiment was repeated with 1.5 % w/w of Piperine and 8 % w/w of 
ginger resin added to the sac. 
In vivo studies using single pass intestinal perfusion method (SPIP) [11]: The intestinal transport of 
Amoxicillin trihydrate was investigated using SPIP technique. Male Wistar rats (200-250 g) were procured 
from Bharat Serum, Thane. Animals were acclimatized for a week before use in the SPIP study. All animal 
experiments were carried out in accordance with guidelines of CPCSEA and the study was approved by the 
Institutional Animal Ethical committee (CPCSEA/ IAEC/SPTM/P-20/2014). Rats were fasted for 12 h (water 
ad libitum) prior to each experiment. Anesthesia was induced with urethane (1.25 gm/kg, i.p.). The 
abdomen was opened with a midline incision and an intestinal segment of approximately 10 cm was 
measured, isolated and cannulated with plastic tubing. Initially, the intestinal segment was rinsed with 
isotonic saline until the outlet solution was clear. Amoxicillin solution (100 µg/ml) was given by a constant 
perfusion at flow rate of 0.2 ml/min. Each perfusion experiment lasted for 60 min and the perfusate was 
quantitavely collected at 15, 30, 45 and 60 min marks. The collected samples were then analyzed by UV 
spectroscopy. Krebs-Ringer buffer solution was used as blank perfusion solution. Phenol red solution was 
added as non-absorbable biomarker to calculate net water flux. Propranolol hydrochloride and Atenolol 
were used as high permeability and low permeability markers to validate the procedure. Experiment was 
repeated with 1.5 % w/w of piperine and 8 % w/w of ginger resin added to the perfusate. Effective 
permeability values were calculated from the steady-state concentrations of Amoxicillin trihydrate in the 
perfusate collected from the outlet. In vivo drug intestinal permeability in humans (Peff,man) can be 
predicted from rat Peff values according to following formula [12]: 
Peff, man = 3.6*Peff,rat + 0.03*10
-4. 
Results and Discussion 
In vitro studies using Franz diffusion cell 
As shown in Table 1, there was a dose dependant and time dependant increase in the diffusion of 
Amoxicillin trihydrate on addition of Piperine. Piperine at a concentration of 1.2 % w/w did not show a 
significant increase at 15 and 30 min but the diffusion increased significantly at 45 and 60 minutes. Piperine 
concentrations of 1.5 and 1.8 % w/w significantly enhanced the diffusion of Amoxicillin trihydrate at 15, 45 
and 60 min (p< 0.0001). However 1.5 and 1.8 % w/w of Piperine additions did not show a significant 
difference in the diffusion of Amoxicillin trihydrate when compared with each other. Hence 1.5 % w/w of 
Piperine was selected for the rest of the studies. 
Use of ginger resin with Amoxcillin trihydrate failed to show a dose dependant increase in the diffusion. 
6 and 8 % w/w of ginger resin demonstrated a significant increase (p<0.0001) in the diffusion which was 
also dose and time dependant. However 7 % w/w of ginger resin failed to show such increase till 45 min, 
but a significant increase (p<0.0001) was observed at 60 min. Hence, we selected 8 % w/w of ginger resin 
for the rest of the experiments. 
 
In vitro studies using non everted gut sac method 
The results for this study are shown in Table 2. 1.5 % w/w Piperine showed a significant increase 
(p<0.0001) in the permeation at all time, however after 45 minutes it reached a plateau and did not show 
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any significant increase in the permeation.  8 % w/w of ginger resin demonstrated a significant reduction in 
the permeation of amoxicillin trihydrate. 
 




Amoxcillin + Piperine 
(µg/ml) 
Amoxcillin + Ginger resin 
(µg/ml) 
1.2 % w/w 1.5 % w/w 1.8 %w/w 6 % w/w 7 % w/w 8 % w/w 
15 min 6.79±0.06 6.05±0.21 8.34±0.07*** 9.89±0.09*** 7.12±0.10*** 4.4±0.050 8.82±0.14*** 
30 min 9.91±0.08 8.83±0.11 10.06±0.12 12.28±0.06* 12.28±0.06 5.55±0.08 27.04±2.86*** 
45 min 10.07±0.08 18.14±0.54*** 29.14±0.25*** 32.18±0.63*** 15.75±0.18*** 10.37±0.11 32.76±0.18*** 
60 min 14.53±0.14 26.35±0.2*** 54.59±0.18*** 54.91±4.30*** 23.38±0.09** 26.55±0.12*** 42.87±4.17*** 
n=6, values are written as mean ± SD, ***p<0.0001 , **p<.001, *p<0.01 when compared to Amoxicillin trihydrate using one way 
ANOVA followed by Bonferroni multiple comparison. 
 
Table 2. Cumulative concentration of Amoxicillin trihydrate using non everted gut sac 
Time  Amoxicillin (µg/ml) 
Amoxcillin + Piperine (µg/ml) 
Amoxcillin + Ginger resin 
(µg/ml) 
1.5 % w/w 8 % w/w 
15 min 15.76±0.14 38.33±0.07*** 7.44±0.05*** 
30 min 27.96±0.07 41.51±0.14*** 15.9±0.08*** 
45 min 35.64±0.07 43.41±0.08*** 20.17±0.12*** 
60 min 50.02±0.31 44.85±0.08 23.51±0.08*** 
n=6, values are written as mean ± SD, ***p<0.0001 when compared to Amoxicillin trihydrate using one 
way ANOVA followed by Bonferroni multiple comparison 
 
In vivo studies using single pass intestinal perfusion method (SPIP) 
Table 3 shows the effective permeability in rats and humans. The Peff of Atenolol was found to be 
0.106±0.012 x 10-4 and 0.4116± 0.041 x 10-4 in rats and humans respectively which is in compliance with 
the reported values 12. Similarly the Peff of Propranolol hydrochloride was found to be 1.14 ±0.082 x 10
-4
 
and 4.134±0.236 x 10-4 in rats and humans respectively, which again complies with the reported values for 
effective permeability [13]. This indicates the validity of the SPIP method. 
For SPIP techniques drugs with Peff,Rats > 0.2 x 10
-4 cm/sec and Peff,Man > 0.7 x 10
-4 cm/sec can be 
considered as highly permeable [14,15]. The Peff of Amoxicillin trihydrate in rats and humans was found to 
be 0.16 x 10−4 cm/ in rat and 0.617 x 10−4 cm/s respectively, thus it can be classified as poorly absorbed 
drug.  1.5 % w/w of piperine increased the permeation by 60 % and 54.13 % in rats and humans 
respectively (p<0.001). 8 % w/w of ginger resin did not show any significant change in the Peff of Amoxicillin 
trihydrate showing no bioenhancement. 
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Table 3. Effective permeability values of Atenolol, Propranolol hydrochloride and Amoxicillin trihydrate 
 
Atenolol Propranolol Amoxicillin 
Amoxicillin + 
Piperine (1.5 % 
w/w) 
Amoxicillin + 
Ginger (8 % w/w) 




 1.140±0.082 x 10
-4
 0.16±0.03 x 10
-4
 0.256±0.021** x 10
-4








 4.134±0.236 x 10
-4
 0.618±0.056 x 10
-4





n=6, values are written as mean ± SD , **p<0.001 when compared to Amoxicillin trihydrate using one way ANOVA followed by 
Dunnetts multiple comparison 
 
We have tried to evaluate enhancement of bioavailability using the in situ SPIP method.  The in situ SPIP 
technique not only preserves the microclimatic conditions of the intestine but also counts the transporter 
activity in the same experimental condition. The result obtained with Piperine confirms the use of this 
method for such type of study. Amoxicillin trihydrate is absorbed from the intestine via passive diffusion 
and active transport using the PEPT1 transporters but at the same time is also a substrate to an energy 
demanding efflux system distinct from the P-glycoprotein mediated transport system which may 
contribute to restricted intestinal absorption [4]. Piperine is known to induce alterations in membrane 
dynamics and permeation characteristics and thereby increase the passive diffusion of Amoxicillin 
trihydrate [16,17]. Piperine is also reported to be inhibitor of drug efflux pump one of them being PgP 
efflux transporter [18], thereby reducing the efflux and enhancing the availability of Amoxicillin trihydrate.  
Piperine at the same time inhibits a number of enzymes involved in metabolism of drugs and nutrients, 
thus reducing the metabolism of drugs and prolonging the drug effect [19]. Moreover it is also known to 
reduce the rate of glucuronidation permitting the entry of active drug substance [19]. Ginger is known to 
enhance the bioavailability by regulating the GIT function [20]. Although there are reports which indicate 
that use of ginger extract enhances the bioavailability of many drugs [21-23], we did not get satisfactory 
results , which is suggestive that bioenhancers working on the gut motility may not be the right candidates 
to be studied by this method. It may also be possible that the ginger extract might be forming a coating 
over the mucosal surface thereby hindering the absorption of Amoxicillin trihydrate. Ginger is reported to 
have prokinetic property [24,25], thus it increases the intestinal motility, due to this the drug remains in 
contact with the mucosal surface for lesser time and hence may not be absorbed to the expected 
significance. 
Conclusions 
The results demonstrate that Piperine can be effectively used in combination with Amoxicillin trihydrate 
to increase the biovaialbility of the later, however ginger resin did not give anticipated results of 
bioenhancement. The combination with piperine may help in reducing the dose, shortening the treatment 
period thus reducing drug-resistance problems. The treatment may be made cost effective, minimizing 
drug toxicity and adverse reactions. In future, formulation may be developed by combining Piperine with 
Amoxicillin trihydrate. 
Such nature derived bioenhancers may be used in combination with other drug classes like, 
antitubercular, antiviral, antifungal and anticancer drugs to enhance the bioavailability. Oral absorption of 
vitamins, minerals, herbal extracts, amino acids and other nutrients can also be enhanced. 
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